None provided


The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Cost saving associated with implementing a stepwise approach to HLA typing of related donors before hematopoietic SCT. Frangoul H, Crowe D (2014) Bone Marrow Transplant 49(6): 850-1
    › Primary publication · 24566707 (PubMed)
  2. Avascular necrosis of bone after allogeneic hematopoietic cell transplantation in children and adolescents. Li X, Brazauskas R, Wang Z, Al-Seraihy A, Baker KS, Cahn JY, Frangoul HA, Gajewski JL, Hale GA, Hsu JW, Kamble RT, Lazarus HM, Marks DI, Maziarz RT, Savani BN, Shah AJ, Shah N, Sorror ML, Wood WA, Majhail NS (2014) Biol Blood Marrow Transplant 20(4): 587-92
    › Primary publication · 24388803 (PubMed) · PMC3959243 (PubMed Central)
  3. Targeted Busulfan therapy with a steady-state concentration of 600-700 ng/mL in patients with sickle cell disease receiving HLA-identical sibling bone marrow transplant. Maheshwari S, Kassim A, Yeh RF, Domm J, Calder C, Evans M, Manes B, Bruce K, Brown V, Ho R, Frangoul H, Yang E (2014) Bone Marrow Transplant 49(3): 366-9
    › Primary publication · 24317124 (PubMed)
  4. Safety of high dose trivalent inactivated influenza vaccine in pediatric patients with acute lymphoblastic leukemia. McManus M, Frangoul H, McCullers JA, Wang L, O'Shea A, Halasa N (2014) Pediatr Blood Cancer 61(5): 815-20
    › Primary publication · 24249544 (PubMed) · PMC4310469 (PubMed Central)
  5. Incidence and risk factors for hypogammaglobulinemia in pediatric patients following allo-SCT. Frangoul H, Min E, Wang W, Chandrasekhar R, Calder C, Evans M, Manes B, Bruce K, Brown V, Ho R, Domm J (2013) Bone Marrow Transplant 48(11): 1456-9
    › Primary publication · 23708706 (PubMed)
  6. Outcome of children who experience disease relapse following allogeneic hematopoietic SCT for hematologic malignancies. Bajwa R, Schechter T, Soni S, Gassas A, Doyle J, Sisler I, Godder K, Tatman D, Rumelhart S, Domm J, Miao Y, Frangoul H (2013) Bone Marrow Transplant 48(5): 661-5
    › Primary publication · 23128573 (PubMed)
  7. Second malignancies after autologous hematopoietic cell transplantation in children. Danner-Koptik KE, Majhail NS, Brazauskas R, Wang Z, Buchbinder D, Cahn JY, Dilley KJ, Frangoul HA, Gross TG, Hale GA, Hayashi RJ, Hijiya N, Kamble RT, Lazarus HM, Marks DI, Reddy V, Savani BN, Warwick AB, Wingard JR, Wood WA, Sorror ML, Jacobsohn DA (2013) Bone Marrow Transplant 48(3): 363-8
    › Primary publication · 22964594 (PubMed) · PMC3525761 (PubMed Central)
  8. Evaluation of HLA matching in unrelated hematopoietic stem cell transplantation for nonmalignant disorders. Horan J, Wang T, Haagenson M, Spellman SR, Dehn J, Eapen M, Frangoul H, Gupta V, Hale GA, Hurley CK, Marino S, Oudshoorn M, Reddy V, Shaw P, Lee SJ, Woolfrey A (2012) Blood 120(14): 2918-24
    › Primary publication · 22829628 (PubMed) · PMC3466972 (PubMed Central)
  9. Acute lymphoblastic leukemia. Alvarnas JC, Brown PA, Aoun P, Ballen KK, Bellam N, Blum W, Boyer MW, Carraway HE, Coccia PF, Coutre SE, Cultrera J, Damon LE, DeAngelo DJ, Douer D, Frangoul H, Frankfurt O, Goorha S, Millenson MM, O'Brien S, Petersdorf SH, Rao AV, Terezakis S, Uy G, Wetzler M, Zelenetz AD, Naganuma M, Gregory KM, National Comprehensive Cancer Network (2012) J Natl Compr Canc Netw 10(7): 858-914
    › Primary publication · 22773801 (PubMed)
  10. Effect of acute graft-versus-host disease on the outcome of second allogeneic hematopoietic stem cell transplant in children. Schechter T, Avila L, Frangoul H, Domm J, Dupuis LL, Naithani R, Zhao X, Pollock-Barziv S, Roifman C, Gassas A, Doyle J (2013) Leuk Lymphoma 54(1): 105-9
    › Primary publication · 22721498 (PubMed)
  11. Comparison of pre-cryopreserved and post-thaw-and-wash-nucleated cell count on major outcomes following unrelated cord blood transplant in children. McManus MP, Wang L, Calder C, Manes B, Evans M, Bruce K, Ho RH, Domm J, Frangoul H (2012) Pediatr Transplant 16(5): 438-42
    › Primary publication · 22533817 (PubMed) · PMC3391317 (PubMed Central)
  12. Long-term follow-up and management guidelines in pediatric patients after allogenic hematopoietic stem cell transplantation. Frangoul H, Najjar J, Simmons J, Domm J (2012) Semin Hematol 49(1): 94-103
    › Primary publication · 22221789 (PubMed)
  13. Castleman disease in a pediatric liver transplant recipient: a case report and literature review. Bonatti HJ, Axt J, Hunter EB, Lott SL, Frangoul H, Gillis L, Correa H, Kelly B (2012) Pediatr Transplant 16(6): E229-34
    › Primary publication · 22032720 (PubMed)
  14. Comparison of pharmacokinetics and safety of voriconazole intravenous-to-oral switch in immunocompromised children and healthy adults. Driscoll TA, Yu LC, Frangoul H, Krance RA, Nemecek E, Blumer J, Arrieta A, Graham ML, Bradfield SM, Baruch A, Liu P (2011) Antimicrob Agents Chemother 55(12): 5770-9
    › Primary publication · 21968355 (PubMed) · PMC3232783 (PubMed Central)
  15. Comparison of pharmacokinetics and safety of voriconazole intravenous-to-oral switch in immunocompromised adolescents and healthy adults. Driscoll TA, Frangoul H, Nemecek ER, Murphey DK, Yu LC, Blumer J, Krance RA, Baruch A, Liu P (2011) Antimicrob Agents Chemother 55(12): 5780-9
    › Primary publication · 21911570 (PubMed) · PMC3232803 (PubMed Central)
  16. Infusion of autologous peripheral blood stem cells in an unrelated donor who developed severe aplastic anemia following stem cell donation. Frangoul H, Navarro WH, Confer DL, Jagasia M (2012) Bone Marrow Transplant 47(6): 869
    › Primary publication · 21874062 (PubMed)
  17. Incidence, risk factors, and outcome of pneumatosis intestinalis in pediatric stem cell transplant recipients. Korhonen K, Lovvorn HN, Koyama T, Koehler E, Calder C, Manes B, Evans M, Bruce K, Ho RH, Domm J, Frangoul H (2012) Pediatr Blood Cancer 58(4): 616-20
    › Primary publication · 21721114 (PubMed)
  18. The quality of privately banked cord blood. Frangoul H, Domm J (2011) Pediatr Blood Cancer 57(7): 1248
    › Primary publication · 21702079 (PubMed)
  19. Outcome of myeloablative conditioning and unrelated donor hematopoietic cell transplantation for childhood acute lymphoblastic leukemia in third remission. Nemecek ER, Ellis K, He W, Bunin NJ, Bajwa RS, Cheerva A, Cairo MS, Dvorak C, Duval M, Davies S, Eapen M, Gross TG, Hussein AA, MacMillan ML, Mehta PA, Pulsipher MA, Seber A, Woolfrey AE, Frangoul HA, Carpenter PA (2011) Biol Blood Marrow Transplant 17(12): 1833-40
    › Primary publication · 21683798 (PubMed) · PMC3372321 (PubMed Central)
  20. A parent's point of view on the American Academy of Pediatrics policy statement: Children as hematopoietic stem cell donors. Revera GH, Frangoul H (2011) Pediatr Blood Cancer 56(4): 515-6
    › Primary publication · 21298733 (PubMed)
  21. Bone marrow transplantation in phosphoglycerate kinase (PGK) deficiency. Rhodes M, Ashford L, Manes B, Calder C, Domm J, Frangoul H (2011) Br J Haematol 152(4): 500-2
    › Primary publication · 21223252 (PubMed)
  22. The effect of obesity on outcome of unrelated cord blood transplant in children with malignant diseases. Pine M, Wang L, Harrell FE, Calder C, Manes B, Evans M, Domm J, Frangoul H (2011) Bone Marrow Transplant 46(10): 1309-13
    › Primary publication · 21151185 (PubMed)
  23. Comparison of outcomes after transplantation of G-CSF-stimulated bone marrow grafts versus bone marrow or peripheral blood grafts from HLA-matched sibling donors for patients with severe aplastic anemia. Chu R, Brazauskas R, Kan F, Bashey A, Bredeson C, Camitta B, Chiang KY, Frangoul H, Gale RP, Gee A, George B, Goldman FD, Gross TG, Gupta V, Hale GA, Isola L, Ispizua AU, Lazarus H, Marsh J, Russell J, Sabloff M, Waller EK, Eapen M (2011) Biol Blood Marrow Transplant 17(7): 1018-24
    › Primary publication · 21034842 (PubMed) · PMC3114180 (PubMed Central)
  24. A unique clinical presentation of X-linked lymphoproliferative syndrome with a novel mutation in SH2D1A and review of the literature. Eckrich MJ, Yang E, Domm J, Ho R, Calder C, Manes B, Bleesing J, Frangoul H (2011) J Pediatr Hematol Oncol 33(1): e39-42
    › Primary publication · 20975587 (PubMed)
  25. Childhood obesity and outcomes after bone marrow transplantation for patients with severe aplastic anemia. Barker CC, Agovi MA, Logan B, Lazarus HM, Ballen KK, Gupta V, Hale GA, Frangoul H, Ho V, Rizzo JD, Pasquini MC, Regimen-Related Toxicity Writing Committee, Center for International Blood and Marrow Transplant Research (2011) Biol Blood Marrow Transplant 17(5): 737-44
    › Primary publication · 20817111 (PubMed) · PMC3035737 (PubMed Central)
  26. Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors. Shaw PJ, Kan F, Woo Ahn K, Spellman SR, Aljurf M, Ayas M, Burke M, Cairo MS, Chen AR, Davies SM, Frangoul H, Gajewski J, Gale RP, Godder K, Hale GA, Heemskerk MB, Horan J, Kamani N, Kasow KA, Chan KW, Lee SJ, Leung WH, Lewis VA, Miklos D, Oudshoorn M, Petersdorf EW, Ringdén O, Sanders J, Schultz KR, Seber A, Setterholm M, Wall DA, Yu L, Pulsipher MA (2010) Blood 116(19): 4007-15
    › Primary publication · 20671124 (PubMed) · PMC2981549 (PubMed Central)
  27. Early lymphocyte reconstitution is associated with improved transplant outcome after cord blood transplantation. Tedeschi SK, Jagasia M, Engelhardt BG, Domm J, Kassim AA, Chinratanalab W, Greenhut SL, Goodman S, Greer JP, Schuening F, Frangoul H, Savani BN (2011) Cytotherapy 13(1): 78-82
    › Primary publication · 20586668 (PubMed)
  28. Treatment of Fanconi anemia patients using fludarabine and low-dose TBI, followed by unrelated donor hematopoietic cell transplantation. Thakar MS, Kurre P, Storb R, Kletzel M, Frangoul H, Pulsipher MA, Leisenring W, Flowers ME, Sandmaier BM, Woolfrey A, Kiem HP (2011) Bone Marrow Transplant 46(4): 539-44
    › Primary publication · 20581880 (PubMed) · PMC2976796 (PubMed Central)
  29. Use of intravenous zanamivir after development of oseltamivir resistance in a critically Ill immunosuppressed child infected with 2009 pandemic influenza A (H1N1) virus. Dulek DE, Williams JV, Creech CB, Schulert AK, Frangoul HA, Domm J, Denison MR, Chappell JD (2010) Clin Infect Dis 50(11): 1493-6
    › Primary publication · 20415572 (PubMed)
  30. Obesity does not preclude safe and effective myeloablative hematopoietic cell transplantation (HCT) for acute myelogenous leukemia (AML) in adults. Navarro WH, Agovi MA, Logan BR, Ballen K, Bolwell BJ, Frangoul H, Gupta V, Hahn T, Ho VT, Juckett M, Lazarus HM, Litzow MR, Liesveld JL, Moreb JS, Marks DI, McCarthy PL, Pasquini MC, Rizzo JD (2010) Biol Blood Marrow Transplant 16(10): 1442-50
    › Primary publication · 20412867 (PubMed) · PMC2933950 (PubMed Central)
  31. H1N1 infection mimicking the clinical presentation of gastrointestinal GVHD in a patient following allo-SCT. Frangoul H, Domm J, Denison MR, Calder C, Black J (2011) Bone Marrow Transplant 46(1): 152-3
    › Primary publication · 20383217 (PubMed)
  32. Advancement of pediatric blood and marrow transplantation research in North America: priorities of the Pediatric Blood and Marrow Transplant Consortium. Pulsipher MA, Horwitz EM, Haight AE, Kadota R, Chen AR, Frangoul H, Cooper LJ, Jacobsohn DA, Goyal RK, Mitchell D, Nieder ML, Yanik G, Cowan MJ, Soni S, Gardner S, Shenoy S, Taylor D, Cairo M, Schultz KR (2010) Biol Blood Marrow Transplant 16(9): 1212-21
    › Primary publication · 20079865 (PubMed) · PMC2891395 (PubMed Central)
  33. Impact of conditioning regimen in allogeneic hematopoetic stem cell transplantation for children with acute myelogenous leukemia beyond first complete remission: a pediatric blood and marrow transplant consortium (PBMTC) study. Sisler IY, Koehler E, Koyama T, Domm JA, Ryan R, Levine JE, Pulsipher MA, Haut PR, Schultz KR, Taylor DS, Frangoul HA (2009) Biol Blood Marrow Transplant 15(12): 1620-7
    › Primary publication · 19896086 (PubMed)
  34. Race and socioeconomic status influence outcomes of unrelated donor hematopoietic cell transplantation. Baker KS, Davies SM, Majhail NS, Hassebroek A, Klein JP, Ballen KK, Bigelow CL, Frangoul HA, Hardy CL, Bredeson C, Dehn J, Friedman D, Hahn T, Hale G, Lazarus HM, LeMaistre CF, Loberiza F, Maharaj D, McCarthy P, Setterholm M, Spellman S, Trigg M, Maziarz RT, Switzer G, Lee SJ, Rizzo JD (2009) Biol Blood Marrow Transplant 15(12): 1543-54
    › Primary publication · 19896078 (PubMed) · PMC2775819 (PubMed Central)
  35. Outcomes of hematologic malignancies after unrelated donor hematopoietic cell transplantation according to place of residence. Loberiza FR, Lee SJ, Klein JP, Hassebroek A, Dehn JG, Frangoul HA, Hahn T, Hale G, Lazarus HM, LeMaistre CF, Maziarz RT, Rizzo JD, Majhail NS (2010) Biol Blood Marrow Transplant 16(3): 368-75
    › Primary publication · 19879951 (PubMed) · PMC2822013 (PubMed Central)
  36. Preengraftment syndrome after unrelated cord blood transplant is a strong predictor of acute and chronic graft-versus-host disease. Frangoul H, Wang L, Harrell FE, Ho R, Domm J (2009) Biol Blood Marrow Transplant 15(11): 1485-8
    › Primary publication · 19822310 (PubMed)
  37. Autologous stem cell transplant in a patient with Down syndrome and relapsed Hodgkin lymphoma. Eckrich MJ, Domm J, Ho R, Whitlock JA, Frangoul H (2009) Pediatr Blood Cancer 53(7): 1327-8
    › Primary publication · 19760777 (PubMed)
  38. Unrelated umbilical cord blood transplantation in children with immune deficiency: results of a multicenter study. Frangoul H, Wang L, Harrell FE, Manes B, Calder C, Domm J (2010) Bone Marrow Transplant 45(2): 283-8
    › Primary publication · 19543326 (PubMed)
  39. Reduced-intensity allogeneic transplantation in pediatric patients ineligible for myeloablative therapy: results of the Pediatric Blood and Marrow Transplant Consortium Study ONC0313. Pulsipher MA, Boucher KM, Wall D, Frangoul H, Duval M, Goyal RK, Shaw PJ, Haight AE, Grimley M, Grupp SA, Kletzel M, Kadota R (2009) Blood 114(7): 1429-36
    › Primary publication · 19528536 (PubMed)
  40. Compound heterozygous c-Mpl mutations in a child with congenital amegakaryocytic thrombocytopenia: functional characterization and a review of the literature. Fox NE, Chen R, Hitchcock I, Keates-Baleeiro J, Frangoul H, Geddis AE (2009) Exp Hematol 37(4): 495-503
    › Primary publication · 19302922 (PubMed) · PMC2694734 (PubMed Central)
  41. Etanercept for treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation. Frangoul H, Koyama T, Domm J (2009) Blood 113(12): 2868-9; author reply 2869
    › Primary publication · 19299655 (PubMed)
  42. Unrelated stem cell transplant for infantile idiopathic myelofibrosis. Domm J, Calder C, Manes B, Crossno C, Correa H, Frangoul H (2009) Pediatr Blood Cancer 52(7): 893-5
    › Primary publication · 19241452 (PubMed)
  43. Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia. Hahn T, McCarthy PL, Zhang MJ, Wang D, Arora M, Frangoul H, Gale RP, Hale GA, Horan J, Isola L, Maziarz RT, van Rood JJ, Gupta V, Halter J, Reddy V, Tiberghien P, Litzow M, Anasetti C, Pavletic S, Ringdén O (2008) J Clin Oncol 26(35): 5728-34
    › Primary publication · 18981462 (PubMed) · PMC2645611 (PubMed Central)
  44. Shortage of chemotherapeutic agents in Iraq and outcome of childhood acute lymphocytic leukemia, 1990-2002. Frangoul H, Al-Jadiry MF, Shyr Y, Ye F, Shakhtour B, Al-Hadad SA (2008) N Engl J Med 359(4): 435-7
    › Primary publication · 18650525 (PubMed)
  45. Comparison of peripheral blood and bone marrow samples for detection of post transplant mixed chimerism. Stumph J, Vnencak-Jones CL, Koyama T, Frangoul H (2008) Bone Marrow Transplant 41(6): 589-90
    › Primary publication · 18037938 (PubMed)
  46. MRI diagnosis of bone marrow relapse in children with ALL. Kan JH, Hernanz-Schulman M, Frangoul HA, Connolly SA (2008) Pediatr Radiol 38(1): 76-81
    › Primary publication · 17994232 (PubMed)
  47. Acyclovir-resistant herpes simplex virus pneumonia post-unrelated stem cell transplantation: a word of caution. Frangoul H, Wills M, Crossno C, Engel M, Domm J (2007) Pediatr Transplant 11(8): 942-4
    › Primary publication · 17976133 (PubMed)
  48. Incidence and outcome of chronic graft-versus-host disease using National Institutes of Health consensus criteria. Jagasia M, Giglia J, Chinratanalab W, Dixon S, Chen H, Frangoul H, Engelhardt B, Goodman S, Greer J, Kassim A, Morgan D, Ruffner K, Schuening F (2007) Biol Blood Marrow Transplant 13(10): 1207-15
    › Primary publication · 17889358 (PubMed)
  49. A prospective study of G-CSF primed bone marrow as a stem-cell source for allogeneic bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium (PBMTC) study. Frangoul H, Nemecek ER, Billheimer D, Pulsipher MA, Khan S, Woolfrey A, Manes B, Cole C, Walters MC, Ayas M, Ravindranath Y, Levine JE, Grupp SA (2007) Blood 110(13): 4584-7
    › Primary publication · 17827386 (PubMed)
  50. Langerhans cell histiocytosis of the frontal sinus mimicking Pott's puffy tumor in a child. Davis BM, Cofer SA, Aulino JM, Frangoul HA, Boulos FI, Turner KM (2007) Otolaryngol Head Neck Surg 137(3): 515-7
    › Primary publication · 17765789 (PubMed)
  51. Mobilization of Ph chromosome-negative peripheral blood stem cells in a child with chronic myeloid leukemia after imatinib-induced complete molecular remission. Woods-Swafford W, Vnencak-Jones CL, Loken MR, Manes B, Frangoul H (2008) Pediatr Blood Cancer 50(3): 639-41
    › Primary publication · 16927371 (PubMed)
  52. Incidence and outcome of idiopathic pneumonia syndrome in pediatric stem cell transplant recipients. Keates-Baleeiro J, Moore P, Koyama T, Manes B, Calder C, Frangoul H (2006) Bone Marrow Transplant 38(4): 285-9
    › Primary publication · 16819436 (PubMed)
  53. Utility of FDG-PET/CT in follow-up of children treated for Hodgkin and non-Hodgkin lymphoma. Rhodes MM, Delbeke D, Whitlock JA, Martin W, Kuttesch JF, Frangoul HA, Shankar S (2006) J Pediatr Hematol Oncol 28(5): 300-6
    › Primary publication · 16772881 (PubMed)
  54. A cord blood transplant recipient with Mycobacterium mucogenicum central venous catheter infection after infusion of tap water. Fleming GA, Frangoul H, Dermody TS, Halasa N (2006) Pediatr Infect Dis J 25(6): 567-9
    › Primary publication · 16732163 (PubMed)
  55. Hospice referral practices for children with cancer: a survey of pediatric oncologists. Fowler K, Poehling K, Billheimer D, Hamilton R, Wu H, Mulder J, Frangoul H (2006) J Clin Oncol 24(7): 1099-104
    › Primary publication · 16505429 (PubMed)
  56. Matched unrelated bone marrow transplantation with reduced-intensity conditioning for leukocyte adhesion deficiency. Engel ME, Hickstein DD, Bauer TR, Calder C, Manes B, Frangoul H (2006) Bone Marrow Transplant 37(7): 717-8
    › Primary publication · 16489359 (PubMed)
  57. Use of G-CSF in matched sibling donor pediatric allogeneic transplantation: a consensus statement from the Children's Oncology Group (COG) Transplant Discipline Committee and Pediatric Blood and Marrow Transplant Consortium (PBMTC) Executive Committee. Grupp SA, Frangoul H, Wall D, Pulsipher MA, Levine JE, Schultz KR (2006) Pediatr Blood Cancer 46(4): 414-21
    › Primary publication · 16463346 (PubMed)
  58. Safety and efficacy of a continuous infusion, patient-controlled antiemetic pump for children receiving emetogenic chemotherapy. Jones E, Koyama T, Ho RH, Kuttesch J, Shankar S, Whitlock JA, Cartwright J, Frangoul H (2007) Pediatr Blood Cancer 48(3): 330-2
    › Primary publication · 16304666 (PubMed)
  59. Allogeneic bone marrow transplantation for chemotherapy-refractory hepatosplenic gammadelta T-cell lymphoma: case report and review of the literature. Domm JA, Thompson M, Kuttesch JF, Acra S, Frangoul H (2005) J Pediatr Hematol Oncol 27(11): 607-10
    › Primary publication · 16282893 (PubMed)
  60. Busulfan/melphalan/antithymocyte globulin followed by unrelated donor cord blood transplantation for treatment of infant leukemia and leukemia in young children: the Cord Blood Transplantation study (COBLT) experience. Wall DA, Carter SL, Kernan NA, Kapoor N, Kamani NR, Brochstein JA, Frangoul H, Goyal RK, Horan JT, Pietryga D, Wagner JE, Kurtzberg J, COBLT Steering Committee (2005) Biol Blood Marrow Transplant 11(8): 637-46
    › Primary publication · 16041314 (PubMed)
  61. A phase II multicenter study of visilizumab, humanized anti-CD3 antibody, to treat steroid-refractory acute graft-versus-host disease. Carpenter PA, Lowder J, Johnston L, Frangoul H, Khoury H, Parker P, Jerome KR, McCune JS, Storer B, Martin P, Appelbaum F, Abonour R, Westervelt P, Anasetti C (2005) Biol Blood Marrow Transplant 11(6): 465-71
    › Primary publication · 15931635 (PubMed)
  62. Pericardial effusion and cardiac tamponade in pediatric stem cell transplant recipients. Rhodes M, Lautz T, Kavanaugh-Mchugh A, Manes B, Calder C, Koyama T, Liske M, Parra D, Frangoul H (2005) Bone Marrow Transplant 36(2): 139-44
    › Primary publication · 15908968 (PubMed)
  63. Two novel CHS1 (LYST) mutations: clinical correlations in an infant with Chediak-Higashi syndrome. Zarzour W, Kleta R, Frangoul H, Suwannarat P, Jeong A, Kim SY, Wayne AS, Gunay-Aygun M, White J, Filipovich AH, Gahl WA (2005) Mol Genet Metab 85(2): 125-32
    › Primary publication · 15896657 (PubMed)
  64. Successful bone marrow harvest during pregnancy. Calder C, Hays SR, Manes B, Lavin VA, Ho RH, Frangoul H (2005) Bone Marrow Transplant 35(6): 631-2
    › Primary publication · 15756288 (PubMed)
  65. Autoimmune hemolytic anemia with giant cell hepatitis: case report and review of the literature. Gorelik M, Debski R, Frangoul H (2004) J Pediatr Hematol Oncol 26(12): 837-9
    › Primary publication · 15591908 (PubMed)
  66. Incidence and clinical complications of vancomycin-resistant enterococcus in pediatric stem cell transplant patients. Tsiatis AC, Manes B, Calder C, Billheimer D, Wilkerson KS, Frangoul H (2004) Bone Marrow Transplant 33(9): 937-41
    › Primary publication · 15034540 (PubMed)
  67. Allogeneic bone marrow transplantation in children with myelodysplastic syndrome or juvenile myelomonocytic leukemia: the Seattle experience. Yusuf U, Frangoul HA, Gooley TA, Woolfrey AE, Carpenter PA, Andrews RG, Deeg HJ, Appelbaum FR, Anasetti C, Storb R, Sanders JE (2004) Bone Marrow Transplant 33(8): 805-14
    › Primary publication · 14755311 (PubMed)
  68. Immune responses to influenza immunization in children receiving maintenance chemotherapy for acute lymphoblastic leukemia. Porter CC, Edwards KM, Zhu Y, Frangoul H (2004) Pediatr Blood Cancer 42(1): 36-40
    › Primary publication · 14752792 (PubMed)
  69. Influenza immunization practices among pediatric oncologists. Porter CC, Poehling KA, Hamilton R, Frangoul H, Cooper WO (2003) J Pediatr Hematol Oncol 25(2): 134-8
    › Primary publication · 12571465 (PubMed)
  70. Kasabach-merritt phenomenon: a retrospective study of treatment with vincristine. Haisley-Royster C, Enjolras O, Frieden IJ, Garzon M, Lee M, Oranje A, de Laat PC, Madern GC, Gonzalez F, Frangoul H, Le Moine P, Prose NS, Adams DM (2002) J Pediatr Hematol Oncol 24(6): 459-62
    › Primary publication · 12218593 (PubMed)
  71. Diabetes insipidus as a presenting symptom of acute myelogenous leukemia. Frangoul HA, Shaw DW, Hawkins D, Park J (2000) J Pediatr Hematol Oncol 22(5): 457-9
    › Primary publication · 11037861 (PubMed)
  72. Increased apoptosis of peripheral blood T cells following allogeneic hematopoietic cell transplantation. Lin MT, Tseng LH, Frangoul H, Gooley T, Pei J, Barsoukov A, Akatsuka Y, Hansen JA (2000) Blood 95(12): 3832-9
    › Primary publication · 10845917 (PubMed)
  73. Phase I study of topotecan administered as a 21-day continous infusion in children with recurrent solid tumors: a report from the Children's Cancer Group. Frangoul H, Ames MM, Mosher RB, Reid JM, Krailo MD, Seibel NL, Shaw DW, Steinherz PG, Whitlock JA, Holcenberg JS (1999) Clin Cancer Res 5(12): 3956-62
    › Primary publication · 10632325 (PubMed)
  74. Complications of acute leukemia. Case one: congenital acute myelogenous leukemia with cutaneous involvement. Frangoul HA, Patterson K (1998) J Clin Oncol 16(9): 3199-200
    › Primary publication · 9738592 (PubMed)